VYLINX Trademark

Trademark Overview


On Wednesday, May 7, 2008, a trademark application was filed for VYLINX with the United States Patent and Trademark Office. The USPTO has given the VYLINX trademark a serial number of 77467610. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 3, 2009. This trademark is owned by Pfizer Inc.. The VYLINX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
vylinx

General Information


Serial Number77467610
Word MarkVYLINX
Filing DateWednesday, May 7, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 3, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2008

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 12, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, August 3, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 3, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 30, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 7, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 17, 2008NOTICE OF PUBLICATION
Wednesday, September 3, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 3, 2008ASSIGNED TO LIE
Friday, August 22, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 20, 2008ASSIGNED TO EXAMINER
Monday, May 12, 2008NEW APPLICATION ENTERED IN TRAM